Veterinary World

     Open access and peer reviewed journal  

ISSN (Online): 2231-0916


Home l Editorial board l Instructions for authors l Reviewer guideline l Open access policy l Archives l FAQ

Open Access

Research (Published online: 17-11-2016)

17. Benefits of pomegranate (Punica granatum Linn) fruit extracts to weight changes, total protein, and uric acid in white rats (Rattus norvegicus) as an animal model of acute renal failure - Hardany Primarizky, Wiwik Misaco Yuniarti and Bambang Sektiari Lukiswanto

Veterinary World, 9(11): 1269-1274



   doi: 10.14202/vetworld.2016.1269-1274



Hardany Primarizky: Department of Veterinary Clinic, Faculty of Veterinary Medicine, Universitas Airlangga, Surabaya, East Java, Indonesia;

Wiwik Misaco Yuniarti: Department of Veterinary Clinic, Faculty of Veterinary Medicine, Universitas Airlangga, Surabaya, East Java, Indonesia;

Bambang Sektiari Lukiswanto: Department of Veterinary Clinic, Faculty of Veterinary Medicine, Universitas Airlangga, Surabaya, East Java, Indonesia;


Received: 21-03-2016, Accepted: 13-10-2016, Published online: 17-11-2016


Corresponding author: Hardany Primarizky, e-mail:

Citation: Primarizky H, Yuniarti WM, Lukiswanto BS (2016) Benefits of pomegranate (Punica granatum Linn) fruit extracts to weight changes, total protein, and uric acid in white rats (Rattus norvegicus) as an animal model of acute renal failure, Veterinary World, 9(11): 1269-1274.

Aim: The occurrence of acute renal failure (ARF) cases continues to increase every year. Some of the cases are due to nephrotoxic effect caused by overdose of antibiotic consumption or abuse of the drug, gentamicin. An antibiotic therapy that can be used to overcome in such a case is the pomegranate extracts. However, until now, studies using pomegranate for cases of ARF have not been done. This study aims to determine changes in body weight, the levels of total protein (TP), and the levels of serum uric acid (UA) as a result of the pomegranate extract consumption.

Materials and Methods: A total number of 32 rats (Rattus norvegicus) were divided into four groups randomly. One group was assigned as the control group (P0) and given intraperitoneal (i.p.) saline and 0.3% carboxy methyl cellulose sodium (CMC) Na; P1 was provided with 80 mg/kg bw/i.p. gentamicin and 0.3% CMC Na orally, P2 was supplied with 80 mg/kg bw/i.p. gentamicin and ellagic acid in 0.3% CMC Na, and P3 was given 80 mg/kg bw/i.p. gentamicin and 150 mg/kg bw pomegranate extract in 0.3% CMC Na. The provision of treatment was carried out in 8 days and followed by making the overthrow of body weight and blood sampling for the examination of study variables.

Results: The results taken by doing the analysis of variance method for the four treatment groups show that the control group (P0) has significant differences from P1, P2, and P3 (p<0.05), but there are no significant differences among the other three treatment groups. Meanwhile, the average values of serum UA levels among P1, P2, and P3 indicate significant differences.

Conclusion: In conclusion, the administration of pomegranate extracts in the treatment of nephrotoxicity toward rats is effective to maintain normal body weight, normal TP levels, and the UA blood serum of the rats. As this study is a preventive therapy, it needs further researches about the effective dose as a curative therapy, its level of effectiveness and its long-term side effects.

Keywords: acute renal failure, gout, pomegranate extract, total protein.

1. Day, R.A., Beverly, W. and Pauline, P. (2009) Brunner and Suddarth's Textbook of Canadian Medical-Surgical Nursing. 6th ed. Lippincott and Wilkins, USA.
2. Tambayong, J. (2001) Patofisiologi. Penerbit Buku Kedokteran, ECG, Jakarta.
3. Bartges, J. and David, J.P. (2011) Nephrology and Urology of Small Animals. 1st ed. Willey-Blackwell, UK.
4. Sutardjo, B. and Fransisca, K. (2012) Dialife Magazine: Kidney Health Information Bulletin. June-July Edition 2012.
PMid:22361136 PMCid:PMC3294181
5. Eurel, J.A. and Brian, L.F. (2006) Textbook of Veterinary Histology. 6th ed. Blackwell Publishing, Asia.
6. Guyton, A.C. and Hall, J.E. (2006) Textbook of Medical Phisiology. 11th ed. WB Saunders Co., Philadelphia, PA. p859-864.
7. Ganong, W.F. (2001) Review of Medical Physiology. McGraw-Hill Companies, Inc., San Fransisco. p675-678.
8. Junquiera, L.C. and Carneiro, L. (2003) Basic Histology: Text & Atlas. 10th ed. The McGraw-Hill Companies Inc., New York.
9. Bijanti, R., Yuliati, M.G.A., Wahjuni, R.S. and Utomo, R.B. (2010) Buku Ajar Patologi Klinik Veteriner. Edisi Pertama. Airlangga University Press, Surabaya.
10. Lansky, E.P. and Newman, R.A. (2007) Review: Punica granatum (pomegranate) and its potential for prevention and treatment of inflamation and cancer. J. Ethnopharmacol., 109(2): 177-206.
11. Budka, D. (2008) Active Ingredients, Their Bioavailibility and the Health Benefits of the Punica granatum Linn (Pomegranate). MSML Research Unit, London.
12. Seeram, N.P., Adam, L.S., Henning, S.M., Niu, Y., Zhang, Y., Nair, M.G. and Heber, D. (2005) In vitro antiproliverative, apoptotic, and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice. J. Nutr. Biochem., 16: 360-367.
13. Koka, R.M., Huang, E. and Lieske, J.C. (2000) Adhesion of uric acid crystals to the surface of renal epithelial cells. Am. J. Physiol. Renal Physiol., 278: F989-F998.
14. Verdecchia, P., Schillaci, G., Reboldi, G.P., Santeusanioa, F., Porcellati, C. and Brunetti, P. (2000) Relation between serum uric acid and risk of cardiovascular disease in essential hypertension; the PIUMA study. Hypertension, 36: 1072-1078.
15. Mazzali, M., Hughes, J., Kim, Y.G., Jefferson, J.A., Kang, D.H., Gordon, K.L., Lan, H.Y., Kivlighn, S. and Johnson, R.J. (2001) Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension, 38: 1101-1106.
16. Kang, D.H., Nakagawa, T., Feng, L., Watanabe, S., Han, L., Mazzali, M., Truong, L., Harris, R. and Johnson, R.J. (2002) A role for uric acid in the progression of renal disease. J. Am. Soc. Nephrol., 13: 2888-2897.
17. Singh, A.P., Muthuraman, A., Jaggi, A.S., Singh, N., Grover, K. and Dhawan, R. (2012) Review: Animal models of acute renal failure. Pharmacol. Rep., 64: 31-44.
18. Mahurkar, N., Mumtaz, M. and Ifthekar, S. (2012) Protective effect of aqueous and methanolic extracts of Lagenaria siceraria seeds in gentamicin induced nephrotoxicity. Int. J. Res. Ayurveda Pharm., 3(3): 443-446.
19. Avdagic, N., Cosovic, E., Nakas-Icindic, E., Mornjakovic, Z., Zaciragic, A. and Hadzovic-Dzuvo, A. (2008) Spirulina platensis protects against renal injury in rats with gentamicin-induced acute tubular necrosis. Bosn. J. Basic Med., 8(4): 331-336.
20. Soenanto, H. (2005) Musnahkan Penyakit Dengan Tanaman Obat. Puspa Swara, Jakarta.
21. Palanysamy, D., Kannan, S.E. and Bhojraj, S. (2007) Protective and therapeutic effects of the Indian medicinal plant Pterocarpus santalinus on D-galactosamine-induced liver damage. Asian J. Tradit. Med., 2(2): 51-57.
22. Ibrahim, M.A.L. and Sayed, A.A.S. (2012) Comparative study of quercetin or/and urate oxidase against gentamicin-induced nephrotoxicity and oxidative stress in rat kidneys. J. Am. Sci., 8(1): 600-607.
23. Roche (2010). Available from: . Last accessed on 07-09-2013.
24. Dalimunthe, A.(2008) Monitoring Effectiveness of Multiple Intravenous Dose of Gentamicin Against Pneumonia Patients Community at Center General Hospital H. Adam Malik. Thesis. University of North Sumatera, Medan. Indonesia.
25. Toblli, J.E., Bevione, P., Di Gennaro, F., Madalena, L., Cao, G. and Angerosa, M. (2012) Review article; understanding the mechanisms of proteinuria: Therapeutic implications. Int. J. Nephrol., 2012: 1-13.
PMid:22844592 PMCid:PMC3398673
26. Seeram, N.P., Schulman, R.N. and Heber, D. (2006) Pomegranate Ancient Roots to Modern Medicine. 1st ed. Taylor and Francis Group, New York. p2-99.
27. Zhang, Y., Wang, D., Lee, R., Henning, S.M. and Heber, D. (2009) Absence of pomegranate ellagitannins in the majority of commercial pomegranate extract: Implications for standardization and quality control. J. Agric. Food Chem., 57(16): 7395-7400.